RemeGen Co.

Traded on the St. Petersburg Stock Exchange
RemeGen is a biotechnology company based in China that focuses on discovering and developing targeted therapies and treatments for cancer, eye, and autoimmune diseases.
RemeGen Co. stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

RemeGen Co. balance sheet

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Capitalization, CN¥
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

RemeGen Co. cash flows

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

RemeGen Co. multipliers

Report period2018 2019 2020 2021 2022 2023
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

RemeGen Co. profitability

Report period2018 2019 2020 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
RemeGen Co. assets
RemeGen Co. cash flows

RemeGen Co. dividend policy

The company does not pay dividends

RemeGen Co. shares

TickerNameTypeNominal valueISINPrice
9995:HKRemeGen Co.Common share-CNE1000048G6HK$17.04
General information
Company nameRemeGen Co.
Tags#hong_kong_spb
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address58 Middle Beijing Road Yantai Development Zone Yantai Area of Shandong Pilot Free Trade Yantai China
Mailing address58 Middle Beijing Road Yantai Development Zone Yantai Area of Shandong Pilot Free Trade Yantai China
Websitewww.remegen.com